Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma

The implementation of immune checkpoint inhibitors (ICI) into the clinical management of different malignancies has largely changed our understanding of cancer treatment. After having proven efficacy in different tumor entities such as malignant melanoma and lung cancer, ICI were intensively tested...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohr, Raphael, Jost-Brinkmann, Fabian, Özdirik, Burcin, Lambrecht, Joeri, Hammerich, Linda, Loosen, Sven H., Luedde, Tom, Demir, Münevver, Tacke, Frank, Roderburg, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042255/
https://www.ncbi.nlm.nih.gov/pubmed/33859646
http://dx.doi.org/10.3389/fimmu.2021.652172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042255/
https://www.ncbi.nlm.nih.gov/pubmed/33859646
http://dx.doi.org/10.3389/fimmu.2021.652172

Ejemplares similares